MR spectroscopy as a tool for in vivo determination of steatosis in liver transplant recipients (Q46722183)

24 December 2017

title

MR spectroscopy as a tool for in vivo determination of steatosis in liver transplant recipients (English)

1 reference

24 December 2017

1 reference

Milan Hájek

1

1 reference

24 December 2017

Monika Dezortová

2

1 reference

24 December 2017

Dita Wagnerová

3

1 reference

24 December 2017

Antonín Skoch

4

1 reference

24 December 2017

Luděk Voska

5

1 reference

24 December 2017

Irena Hejlová

6

1 reference

24 December 2017

Pavel Trunečka

7

1 reference

24 December 2017

publication date

10 July 2011

1 reference

24 December 2017

Magnetic Resonance Materials in Physics, Biology and Medicine

published in

1 reference

24 December 2017

volume

24

1 reference

24 December 2017

issue

5

1 reference

24 December 2017

page(s)

297-304

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1007/s10334-011-0264-9

exact match

0 references

cites work

Steatosis as a risk factor in liver surgery

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0264-9

Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0264-9

Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0264-9

Non-alcoholic fatty liver disease after liver transplantation: a case of nurture and nature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0264-9

In vivo MRS measurement of liver lipid levels in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0264-9

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0264-9

Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0264-9

Liver fat content determined by magnetic resonance imaging and spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0264-9

Noninvasive quantitation of human liver steatosis using magnetic resonance and bioassay methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0264-9

Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0264-9

Comparison of fat-water MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0264-9

The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0264-9

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0264-9

Histological assessment of non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0264-9

Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0264-9

Mapping of liver fat with triple-echo gradient echo imaging: validation against 3.0-T proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0264-9

Evaluation of the severity of chronic hepatitis C with 3-T1H-MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0264-9

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0264-9

Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0264-9

Assessment of Liver Fibrosis and Steatosis in PBC With FibroScan, MRI, MR-spectroscopy, and Serum Markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0264-9

Reproducibility of 3.0 Tesla magnetic resonance spectroscopy for measuring hepatic fat content

21 January 2018

1 reference

12 December 2020

Risk factors for primary dysfunction after liver transplantation--a multivariate analysis

1 reference

12 December 2020

Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography

1 reference

12 December 2020

Non-invasive assessment of hepatic fat accumulation in chronic hepatitis C by 1H magnetic resonance spectroscopy

1 reference

12 December 2020

Quantification of liver fat using magnetic resonance spectroscopy

1 reference

12 December 2020

Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis

1 reference

12 December 2020

10.1007/S10334-011-0264-9

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

21744232

1 reference

24 December 2017